| Literature DB >> 28717522 |
Fenglian Zhao1, Junling Yang1, Ranji Cui1.
Abstract
Hypoxemia is a common complication of the diseases associated with the central nervous system, and neurons are highly sensitive to the availability of oxygen. Neuroplasticity is an important property of the neural system controlling breathing, memory, and cognitive ability. However, the underlying mechanism has not yet been clearly elucidated. In recent years, several pieces of evidence have highlighted the effect of hypoxic injury on neuronal plasticity in the pathogenesis and treatment of mood disorder. Therefore, the present study reviewed the relevant articles regarding hypoxic injury and neuronal plasticity and discussed the pathological changes and physiological functions of neurons in hypoxemia in order to provide a translational perspective to the relevance of hypoxic injury and mood disorder.Entities:
Mesh:
Year: 2017 PMID: 28717522 PMCID: PMC5498932 DOI: 10.1155/2017/6986983
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Changes of neural plasticity induced by hypoxic-ischemic injury in various brain regions.
| Brain region | Changes of neural plasticity | Mechanisms |
|---|---|---|
| Hippocampus | Synaptic plasticity | (1) Triggering of LTD via ROS and NOS
|
| Volumetric changes | (1) Hippocampal atrophy and neurons apoptosis
| |
| Apoptosis | (1) A severe loss of neurons induced by activation of MAPK signaling pathways
| |
| Misfolded/unfolded protein | (1) Increased production of ROS | |
|
| ||
| Prefrontal cortex | Synaptic plasticity | (1) Increased density of the GABAergic neurons impair the network activity within PFC
|
| Activity in vmPFC and dlPFC | (1) Increasing the acetylcholine release by enhancing the activation of G protein | |
| Immunoreactive cells and cytokine changes | (1) Upregulated expression of molecules such as VEGF, Hif-1, and Glut1
| |
| Volumetric changes | (1) Increased neuronal death and ghost cells
| |
|
| ||
| Amygdala | Synaptic plasticity | (1) Decreased expression of NPY
|
| Volumetric changes | (1) Smaller gray matter volume in the amygdala and decreased volume of the left amygdala
| |
|
| ||
| Signaling pathways | Upregulation of Abcc1, Abcc2, and Abcc4 mRNA expression at the BBB | (1) Regulated through Nrf2 signaling |
| Activation of BDNF-TrkB signaling pathway | (1) The circulating levels of BDNF increased | |
| Enhancement of ERK1/2-CREB-BDNF signaling pathway | (1) The circulating levels of BDNF increased | |
| Activation of STAT3 signaling pathway | (1) Phosphorylation of STAT3 | |
| Triggering cAMP/PKA signaling pathway | (1) Increased release of CRF | |
| Dysregulation of NMDARs-Wnt-catenin signaling | (1) Decreased expression of NMDARs | |